Quince Therapeutics News

Quince Therapeutics | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Apr 11 16:41 ET

Quince Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Apr 1 17:23 ET

Quince Therapeutics | 10-K: Annual report

Apr 1 16:54 ET

Quince Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Patni Rajiv

Feb 15 18:18 ET

Quince Therapeutics | 3: Initial statement of beneficial ownership of securities-Director Patni Rajiv

Feb 15 18:13 ET

Quince Therapeutics | 8-K: Current report

Feb 15 16:03 ET

Quince Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-TANG CAPITAL PARTNERS, LP(7.5%),Tang Capital Management, LLC(7.5%), etc.

Feb 14 16:04 ET

Quince Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Sofinnova Capital VIII (“SC VIII”)(5.1%),Sofinnova Partners SAS, a French corporation (“SP SAS”)(5.1%), etc.

Feb 12 09:04 ET

Quince Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BML Investment Partners, L.P.(0.0%),Braden M Leonard(0.0%)

Feb 7 10:51 ET

Quince Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Ryan Charles S.

Feb 2 18:06 ET

Quince Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Hannah Brendan

Feb 2 17:56 ET

Quince Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Thye Dirk

Feb 2 17:52 ET

Quince Therapeutics | 8-K: Current report

Jan 29 16:07 ET

Quince Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Thye Dirk

Jan 17 00:00 ET

Quince Therapeutics | 8-K/A: Current report (Amendment)

Jan 5 00:00 ET

Quince Therapeutics | 8-K: Current report

Jan 3 00:00 ET

Quince Therapeutics | 8-K: Current report

Dec 22, 2023 16:08 ET

Quince Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Lamond David

Dec 14, 2023 18:21 ET

Quince Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Genextra S.p.A.(5.89%),Francesco Micheli(5.89%), etc.

Dec 14, 2023 17:51 ET

Quince Therapeutics | 8-K: Current report

Dec 8, 2023 16:06 ET